Interim data from a phase 3 study evaluating tecovirimat for the treatment of human mpox virus showed the antiviral did not improve time to lesion resolution compared with placebo.

The sBLA submission included results from the randomized, parallel-arm, placebo-controlled and active-controlled trial foresiGHt.

A higher risk of liver transplant and death was observed in Ocaliva-treated patients vs those who received placebo.

Findings seen among children and adolescents with type 1 diabetes and nonoptimal control with traditional treatment ...

Number of people with at least one episode of HSV-attributable genital ulcer disease was 187.9 and 16.7 million for HSV-2, HSV-1 in 2020 ...

(HealthDay News) — Adults receiving chiropractic spinal manipulative therapy (SMT) for tension-type headache have a significantly lower likelihood of butalbital prescription, according to a study ...

The health system defended itself by claiming it had done nothing wrong, and that Dr T had a clear duty to inform it of the ...

The burden of respiratory syncytial virus (RSV) in young children continues to be high in the United States, according to a study published online Dec. 9 in JAMA Pediatrics. Heidi L. Moline, MD, MPH, ...

Health span-lifespan gaps, resulting from health-adjusted life expectancy lagging behind longevity gains, are growing worldwide, with women exhibiting a large ...

Adults with asthma with cost-related medication nonadherence more likely to have asthma attacks, ED visits for asthma ...

The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), as a single agent, for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has ...

The newly approved regimen is expected to simplify administration and potentially reduce medication errors and dose-related reactions.